The Society for Immunotherapy of Cancer (SITC) is proud to collaborate with the Society of Interventional Oncology (SIO) for joint sessions, "When Combination Therapies Fail in HCC: Scientific Insights and Future Directions" and "Intratumoral Therapies in IO: Mechanisms, Delivery and Clinical Integration" at the upcoming SIO 2026 NEXT Summit. These sessions will feature SITC and SIO experts, and the 2026 program expands its scope beyond HCC and liver cancers to include additional disease states, highlighting novel therapeutic applications and next-generation combination approaches that reflect the rapidly evolving patient care landscape and support forward-looking treatment strategies.
The SIO 2026 NEXT Summit will be held May 28-29, 2026 at the Gleacher Center in Chicago, IL.